Hybrid anilinoquinazoline-icosahedral boranes with anti-glioma activity have been developed. It is is proposed that once the compound reaches the malignant cell, the presence of some transmembrane tyrosine kinase receptors, overproduced by unhealthy cell, provokes its accumulation in the tissue enriching with boron for further BNCT. Both structural motifs, anilinoquinazolinyl and icosahedral boron clusters, are connected using 1,3-dipolar cycloaddition or Sonogashira cross-coupling processes.

For more information, see the Communication by Clara Viñas et al. on https://doi.org/10.1002/chem.201701965 page 9233 ff.

The Seminars and Training Committee kindly invites you to the following ICMAB Invited Seminar: Carborane functionalization and its potential applications by Prof. Hong YAN,School of Chemistry and Chem...

Biomaterials and materials for drug delivery, therapy, diagnostics and sensing